AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31422715 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxibustion
Number of subjects: 48
Study 31422715 — intervention group
Group type: COMPARATOR
Intervention: Control (pneumatic circulation with compression garments)
Number of subjects: 48
Study 28867310 — intervention group
Group type: EXPERIMENTAL
Intervention: High baseline negative affect (NA)
Number of subjects: 230
Study 28867310 — intervention group
Group type: COMPARATOR
Intervention: Low baseline negative affect (NA)
Number of subjects: 230
Study 28867310 — intervention group
Group type: EXPERIMENTAL
Intervention: High baseline positive affect (PA)
Number of subjects: 230
Study 28867310 — intervention group
Group type: COMPARATOR
Intervention: Low baseline positive affect (PA)
Number of subjects: 230
Study 26590506 — intervention group
Group type: EXPERIMENTAL
Intervention: 9-hour duty day with multiple take-offs and landings
Number of subjects: 24
Study 26590506 — intervention group
Group type: COMPARATOR
Intervention: 9-hour duty day with a single take-off and landing
Number of subjects: 24
Study 25188489 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation with black standardized patients
Number of subjects: 31
Study 25188489 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation with white standardized patients
Number of subjects: 31
Study 25188489 — intervention group
Group type: COMPARATOR
Intervention: Privately insured black patients
Number of subjects: 31
Study 25188489 — intervention group
Group type: COMPARATOR
Intervention: Medicaid-insured white patients
Number of subjects: 31
Study 21974992 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal repair with mesh
Number of subjects: 65
Study 21974992 — intervention group
Group type: COMPARATOR
Intervention: Vaginal repair without mesh
Number of subjects: 65
Study 19095871 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4% ropivacaine (basal 4 mL/h, bolus 2 mL)
Number of subjects: 50
Study 19095871 — intervention group
Group type: COMPARATOR
Intervention: 0.2% ropivacaine (basal 8 mL/h, bolus 4 mL)
Number of subjects: 50
Study 19095871 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4% ropivacaine
Number of subjects: 50
Study 19095871 — intervention group
Group type: COMPARATOR
Intervention: 0.2% ropivacaine
Number of subjects: 50
Study 17545351 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerised decision support tool
Number of subjects: 30
Study 17545351 — intervention group
Group type: COMPARATOR
Intervention: Standard gamble values elicitation exercise
Number of subjects: 30
Study 14670395 — intervention group
Group type: EXPERIMENTAL
Intervention: Empowerment program
Number of subjects: 50
Study 14670395 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study 11897179 — intervention group
Group type: EXPERIMENTAL
Intervention: Enrolled African American smokers who returned for randomization
Number of subjects: 287
Study 11897179 — intervention group
Group type: COMPARATOR
Intervention: Enrolled African American smokers who did not return for randomization
Number of subjects: 287
Study 10442506 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine 5 mg daily (doubled to 7.1 mg daily if diastolic blood pressure > 90 mmHg)
Number of subjects: 24
Study 10442506 — intervention group
Group type: COMPARATOR
Intervention: Enalapril 20 mg daily (doubled dosage if diastolic blood pressure > 90 mmHg)
Number of subjects: 24
Study 7503838 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 85
Study 7503838 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen (with at least 70% compliance)
Number of subjects: 85
Study 7503838 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study 2217684 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxycillin (3 g) twice daily for 32 weeks
Number of subjects: 38
Study 2217684 — intervention group
Group type: COMPARATOR
Intervention: Placebo twice daily for 32 weeks
Number of subjects: 38
Study 623256 — intervention group
Group type: EXPERIMENTAL
Intervention: Underwater weighing
Number of subjects: 67
Study 623256 — intervention group
Group type: COMPARATOR
Intervention: Water displacement
Number of subjects: 67
Study 623256 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of both techniques
Number of subjects: 67
Study 30621837 — intervention group
Group type: EXPERIMENTAL
Intervention: Unguided Internet CBT-I
Number of subjects: 95
Study 27939495 — intervention group
Group type: EXPERIMENTAL
Intervention: Tachyarrhythmias (20% of subjects)
Number of subjects: 544
Study 27939495 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrioventricular block (4% of subjects)
Number of subjects: 544
Study 26316351 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 Hz cerebellar rTMS
Number of subjects: 17
Study 26316351 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal train length of 250 pulses of 10 Hz cerebellar rTMS
Number of subjects: 17
Study 26316351 — intervention group
Group type: COMPARATOR
Intervention: Sham cerebellar rTMS
Number of subjects: 17
Study 23508339 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-order practice
Number of subjects: 25
Study 23508339 — intervention group
Group type: COMPARATOR
Intervention: Random-order practice
Number of subjects: 25
Study 21513688 — intervention group
Group type: EXPERIMENTAL
Intervention: Very-low-dose naltrexone (VLNTX) 0.125 or 0.250 mg/day
Number of subjects: 174
Study 21513688 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 174
Study 19141364 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness meditation stress coping program (90-min sessions for eight weeks)
Number of subjects: 41
Study 19141364 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 41
Study 17679044 — intervention group
Group type: EXPERIMENTAL
Intervention: A/B antihypertensive agents
Number of subjects: 175
Study 17679044 — intervention group
Group type: COMPARATOR
Intervention: C/D antihypertensive agents
Number of subjects: 175
Study 15385805 — intervention group
Group type: EXPERIMENTAL
Intervention: ISIS 2302 (0.05, 0.5, 1.0, or 2.0 mg/kg)
Number of subjects: 56
Study 15385805 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 15385805 — intervention group
Group type: EXPERIMENTAL
Intervention: ISIS 2302
Number of subjects: 56
Study 11351767 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined DTP-HBV vaccine
Number of subjects: 120
Study 11351767 — intervention group
Group type: COMPARATOR
Intervention: Separate DTP and HBV vaccines
Number of subjects: 120
Study 9562774 — intervention group
Group type: EXPERIMENTAL
Intervention: New diagnostic instruments such as electrocardiography and new research designs such as randomized trials
Number of subjects: 0
Study 9562774 — intervention group
Group type: EXPERIMENTAL
Intervention: Development of a questionnaire on the health of the elderly and introduction of the concept of activities of daily living
Number of subjects: 0
Study 9562774 — intervention group
Group type: EXPERIMENTAL
Intervention: Methodological problems encountered by researchers
Number of subjects: 0
Study 9829346 — intervention group
Group type: EXPERIMENTAL
Intervention: History of diabetes (self-reported)
Number of subjects: 3654
Study 9829346 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated fasting plasma glucose (FPG)
Number of subjects: 3654
Study 9829346 — intervention group
Group type: EXPERIMENTAL
Intervention: Impaired fasting glucose (FPG)
Number of subjects: 3654
Study 9829346 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes history
Number of subjects: 3654
Study 9829346 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking status
Number of subjects: 3654
Study 1750041 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy performed by approved surgeons
Number of subjects: 164
Study 1750041 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy performed on asymptomatic patients
Number of subjects: 164
Study 6315038 — intervention group
Group type: EXPERIMENTAL
Intervention: DAMME (0.25 mg)
Number of subjects: 6
Study 6315038 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 6
Study 30877186 — intervention group
Group type: EXPERIMENTAL
Intervention: 17.5 mg PF‐06372865
Number of subjects: 7
Study 30877186 — intervention group
Group type: EXPERIMENTAL
Intervention: 52.5 mg PF‐06372865
Number of subjects: 7
Study 30877186 — intervention group
Group type: COMPARATOR
Intervention: 2 mg lorazepam (active control)
Number of subjects: 7
Study 30877186 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 28064115 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 50
Study 28064115 — intervention group
Group type: COMPARATOR
Intervention: Placebo followed by Duloxetine
Number of subjects: 50
Study 28064115 — intervention group
Group type: EXPERIMENTAL
Intervention: Desvenlafaxine or Bupropion (for duloxetine non-responders)
Number of subjects: 50
Study 27055214 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjunctival autograft (CAG)
Number of subjects: 33
Study 27055214 — intervention group
Group type: COMPARATOR
Intervention: Amniotic membrane transplantation (AMT)
Number of subjects: 33
Study 24517906 — intervention group
Group type: EXPERIMENTAL
Intervention: BoNTA (5 U)
Number of subjects: 0
Study 24517906 — intervention group
Group type: COMPARATOR
Intervention: Saline (0.2 mL)
Number of subjects: 0
Study 22237063 — intervention group
Group type: EXPERIMENTAL
Intervention: Leptin (replacement doses)
Number of subjects: 10
Study 22237063 — intervention group
Group type: COMPARATOR
Intervention: Placebo (twice-daily injections)
Number of subjects: 10
Study 21182601 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylephrine
Number of subjects: 60
Study 21182601 — intervention group
Group type: COMPARATOR
Intervention: Mephentermine
Number of subjects: 60
Study 18222414 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry surface
Number of subjects: 0
Study 18222414 — intervention group
Group type: EXPERIMENTAL
Intervention: Wet surface
Number of subjects: 0
Study 18222414 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycerol-contaminated surface
Number of subjects: 0
Study 18222414 — intervention group
Group type: EXPERIMENTAL
Intervention: Low load (0 kg)
Number of subjects: 0
Study 18222414 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium load (295 kg)
Number of subjects: 0
Study 18222414 — intervention group
Group type: EXPERIMENTAL
Intervention: High load (568 kg)
Number of subjects: 0
Study 15733152 — intervention group
Group type: EXPERIMENTAL
Intervention: Scaling and root planing
Number of subjects: 13
Study 15733152 — intervention group
Group type: COMPARATOR
Intervention: Modified Widman flap
Number of subjects: 13
Study 12527321 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertonic saline injections (0.1 ml of 0.9%, 2%, 4%, and 6% and 0.2 ml of 2% and 4%)
Number of subjects: 10
Study 12527321 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous infusion of 4% saline
Number of subjects: 10
Study 12527321 — intervention group
Group type: COMPARATOR
Intervention: Placebo (isotonic saline injections)
Number of subjects: 10
Study 10577682 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha‐Cradle mattress (AM)
Number of subjects: 30
Study 10577682 — intervention group
Group type: EXPERIMENTAL
Intervention: Orfit cast (OC)
Number of subjects: 30
Study 10577682 — intervention group
Group type: COMPARATOR
Intervention: No immobilisation device (NI)
Number of subjects: 30
Study 9410673 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended drainage operation according to Frey
Number of subjects: 0
Study 9410673 — intervention group
Group type: COMPARATOR
Intervention: Simple drainage procedures (longitudinal pancreaticojejunostomy)
Number of subjects: 0
Study 8195851 — intervention group
Group type: EXPERIMENTAL
Intervention: Brodimoprim 200 mg tablets (2 tablets on the first day, 1 tablet on following days)
Number of subjects: 80
Study 8195851 — intervention group
Group type: COMPARATOR
Intervention: Josamycin 500 mg tablets (3 tablets/day)
Number of subjects: 80
Study 8195851 — intervention group
Group type: EXPERIMENTAL
Intervention: Brodimoprim
Number of subjects: 80
Study 8195851 — intervention group
Group type: COMPARATOR
Intervention: Brodimoprim and Josamycin
Number of subjects: 80
Study 3515951 — intervention group
Group type: EXPERIMENTAL
Intervention: Single 2 gm dose of cefotetan
Number of subjects: 70
Study 3515951 — intervention group
Group type: COMPARATOR
Intervention: Multidose cefoxitin (2 gm every 4 hours for three doses)
Number of subjects: 70
Study 31903435 — intervention group
Group type: EXPERIMENTAL
Intervention: Active VNS (0.8 mA) paired with upper limb rehabilitation
Number of subjects: 120
Study 31903435 — intervention group
Group type: COMPARATOR
Intervention: Control VNS (0.0 mA) paired with upper limb rehabilitation
Number of subjects: 120
Study 29335039 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole eggs (EGG)
Number of subjects: 20
Study 29335039 — intervention group
Group type: EXPERIMENTAL
Intervention: Egg whites (WHITE)
Number of subjects: 20
Study 29335039 — intervention group
Group type: COMPARATOR
Intervention: Glucose (GLU)
Number of subjects: 20
Study 29335039 — intervention group
Group type: EXPERIMENTAL
Intervention: Egg yolks (YOLK)
Number of subjects: 20
Study 26781404 — intervention group
Group type: EXPERIMENTAL
Intervention: Volume-targeted ventilation (VTV)
Number of subjects: 52
Study 26781404 — intervention group
Group type: COMPARATOR
Intervention: Pressure-controlled ventilation (PCV)
Number of subjects: 52
Study 23486918 — intervention group
Group type: EXPERIMENTAL
Intervention: dual-tDCS
Number of subjects: 19
Study 23486918 — intervention group
Group type: COMPARATOR
Intervention: sham
Number of subjects: 19
Study 22103390 — intervention group
Group type: COMPARATOR
Intervention: Palpation-guided arthrocentesis with a conventional 20-mL syringe
Number of subjects: 64
Study 22103390 — intervention group
Group type: EXPERIMENTAL
Intervention: US-guided arthrocentesis with a 25-mL reciprocating procedure device (RPD) mechanical aspirating syringe
Number of subjects: 64
Study 22103390 — intervention group
Group type: EXPERIMENTAL
Intervention: US-guided arthrocentesis with a 60-mL automatic aspirating syringe
Number of subjects: 64
Study 19067474 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate 400 microg administered via a dry powder inhaler once daily in the evening (MF‐DPI 400 microg qd pm)
Number of subjects: 20
Study 19067474 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered between 6 pm and 8 pm for 14 days
Number of subjects: 20
Study 17469029 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shock-wave lithotripsy (ESWL)
Number of subjects: 284
Study 16045025 — intervention group
Group type: EXPERIMENTAL
Intervention: Isobaric bupivacaine (3.0 mL, 15 mg)
Number of subjects: 160
Study 16045025 — intervention group
Group type: COMPARATOR
Intervention: Hyperbaric bupivacaine (3.0 mL, 15 mg)
Number of subjects: 160
Study 11896484 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Treatment (CBT)
Number of subjects: 0
Study 11896484 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy
Number of subjects: 0
Study 11896484 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help
Number of subjects: 0
Study 11896484 — intervention group
Group type: EXPERIMENTAL
Intervention: SSRIs (Selective Serotonin Reuptake Inhibitors)
Number of subjects: 0
Study 11896484 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss treatment
Number of subjects: 0
Study 8123997 — intervention group
Group type: EXPERIMENTAL
Intervention: bFGF (bovine fibroblast growth factor) administered intramuscularly at dosages of 0.4 or 0.28 microgram kg-1, once or twice a month, over 7-12 months
Number of subjects: 95
Study 8123997 — intervention group
Group type: EXPERIMENTAL
Intervention: bFGF (bovine fibroblast growth factor) administered intramuscularly
Number of subjects: 95
Study 8123997 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 95
Study 2442538 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous enalaprilat (ET) 5 mg
Number of subjects: 24
Study 2442538 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral enalapril (E) 10 mg
Number of subjects: 24
Study 2442538 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous enalapril (E) 5 mg
Number of subjects: 24
Study 2442538 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral lisinopril (LI) 10 mg
Number of subjects: 24
Study 2442538 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous lisinopril (LI) 5 mg
Number of subjects: 24
Study 29758176 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-administered DMPA-SC
Number of subjects: 731
Study 29758176 — intervention group
Group type: COMPARATOR
Intervention: Provider-administered DMPA-SC
Number of subjects: 731
Study 28241271 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard pillbox
Number of subjects: 53480
Study 28241271 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital timer cap
Number of subjects: 53480
Study 28241271 — intervention group
Group type: EXPERIMENTAL
Intervention: Pill bottle strip with toggles
Number of subjects: 53480
Study 28241271 — intervention group
Group type: COMPARATOR
Intervention: Control (no device)
Number of subjects: 53480
Study 26301654 — intervention group
Group type: EXPERIMENTAL
Intervention: Invasive strategy (IS)
Number of subjects: 3670
Study 24649788 — intervention group
Group type: EXPERIMENTAL
Intervention: Dural puncture epidural (DPE) analgesia
Number of subjects: 112
Study 24649788 — intervention group
Group type: COMPARATOR
Intervention: Continuous labor epidural (CLE) analgesia
Number of subjects: 112
Study 20804848 — intervention group
Group type: EXPERIMENTAL
Intervention: Caloric orangeade (10% sucrose)
Number of subjects: 10
Study 20804848 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-caloric orangeade (non-caloric sweeteners)
Number of subjects: 10
Study 20804848 — intervention group
Group type: COMPARATOR
Intervention: Small sips (5 mL)
Number of subjects: 10
Study 20804848 — intervention group
Group type: COMPARATOR
Intervention: Large sips (20 mL)
Number of subjects: 10
Study 18577289 — intervention group
Group type: EXPERIMENTAL
Intervention: Levodopa administration (on condition)
Number of subjects: 20
Study 18577289 — intervention group
Group type: COMPARATOR
Intervention: No drug administration (off condition)
Number of subjects: 20
Study 18577289 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 20
Study 16842440 — intervention group
Group type: EXPERIMENTAL
Intervention: Peginterferon alpha‐2a (40 kDa) plus ribavirin
Number of subjects: 0
Study 16842440 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 0
Study 14604194 — intervention group
Group type: COMPARATOR
Intervention: High protein diet (1.4 g natural protein/kg target weight/day and 35 kcal/kg target weight/day)
Number of subjects: 100
Study 14604194 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium caseinate (0.7 g calcium caseinate plus 0.7 g natural protein diet/kg target weight/day and 35 kcal/kg target weight/day)
Number of subjects: 100
Study 10790464 — intervention group
Group type: EXPERIMENTAL
Intervention: rHuEPO (1250 units/kg/week; IV)
Number of subjects: 114
Study 10790464 — intervention group
Group type: COMPARATOR
Intervention: Placebo (late group)
Number of subjects: 114
Study 9148240 — intervention group
Group type: EXPERIMENTAL
Intervention: Amyloid beta protein (A beta), A beta 40, A beta 42, and transthyretin (TTR) immunohistochemical localization
Number of subjects: 0
Study 8450109 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral marital therapy
Number of subjects: 55
Study 8450109 — intervention group
Group type: EXPERIMENTAL
Intervention: Insight-oriented marital therapy
Number of subjects: 55
Study 8450109 — intervention group
Group type: EXPERIMENTAL
Intervention: Termination measures of negative marital affect and poor communication skills
Number of subjects: 55
Study 3300270 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium fluoride (0.05%) mouthrinse, nightly rinse
Number of subjects: 20
Study 3300270 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly topical APF treatment (1.2% fluoride)
Number of subjects: 20
Study 3300270 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly topical APF treatment (1.2% fluoride) and sodium fluoride (0.05%) mouthrinse, nightly rinse
Number of subjects: 20
Study 3300270 — intervention group
Group type: COMPARATOR
Intervention: Control group (dentifrice only)
Number of subjects: 20
Study 31183796 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold jumbo forceps polypectomy (JFP)
Number of subjects: 151
Study 31183796 — intervention group
Group type: COMPARATOR
Intervention: Cold snare polypectomy (CSP)
Number of subjects: 151
Study 29713800 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunitrazepam 1 mg
Number of subjects: 28
Study 29713800 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 27658756 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingent vouchers (CV) for smoking abstinence
Number of subjects: 340
Study 27658756 — intervention group
Group type: COMPARATOR
Intervention: Noncontingent vouchers (NV)
Number of subjects: 340
Study 27658756 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingent vouchers (CV)
Number of subjects: 340
Study 27658756 — intervention group
Group type: EXPERIMENTAL
Intervention: NRT (Nicotine Replacement Therapy)
Number of subjects: 340
Study 26351027 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuation of antihypertensive treatment (n=47)
Number of subjects: 203
Study 26351027 — intervention group
Group type: COMPARATOR
Intervention: Discontinuation of antihypertensive treatment (n=55)
Number of subjects: 203
Study 26351027 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall BP parameters (systolic, diastolic, mean arterial pressure, pulse pressure, BP changes on standing)
Number of subjects: 203
Study 26351027 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgroups with small vessel-related cerebral pathologies, lower cognition, or diabetes mellitus
Number of subjects: 203
Study 24289740 — intervention group
Group type: EXPERIMENTAL
Intervention: Online psycho-educational intervention
Number of subjects: 0
Study 24289740 — intervention group
Group type: COMPARATOR
Intervention: Brief generic information about depression (control)
Number of subjects: 0
Study 21472373 — intervention group
Group type: COMPARATOR
Intervention: Melphalan plus prednisone (MP)
Number of subjects: 284
Study 21472373 — intervention group
Group type: EXPERIMENTAL
Intervention: Thalidomide with melphalan/prednisone (MPT)
Number of subjects: 284
Study 18538774 — intervention group
Group type: EXPERIMENTAL
Intervention: pioglitazone
Number of subjects: 5238
Study 18538774 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 5238